Delivery Order SPE2DX22D0010-SPE2D826FCJ50
- Not listed
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with a ceiling value of $6,005.34 and an ultimate completion date of December 3, 2025. The contract does not carry a set-aside designation, and performance is based at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,194.33 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 50 mg, a controlled-release pain management pharmaceutical. The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with performance scheduled for completion by June 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this medical supply delivery....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order has a ceiling value of $10,219.87 and an ultimate completion date of January 5, 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for NUCYNTA ER 100 MG tablets (60-count) by the Defense Logistics Agency on January 12, 2026. The contract is structured as a firm fixed-price delivery order with a ceiling value of $2,609.58 and an ultimate completion date of January 13, 2026. This award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's capability to meet federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,205.75 firm fixed-price delivery order by the Defense Logistics Agency on June 2, 2025, for Nucynta ER 200 mg tablets (60-count supply). The contract, which carries an ultimate completion date of June 3, 2025, represents a non-competitive award and serves the federal medical supply chain supporting military and veteran healthcare systems. This delivery order is issued...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $9,338.00 to AmerisourceBergen Drug Corp for the supply of Nucynta ER Tabs 200mg, a pain management pharmaceutical. The contract is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. The order was awarded on January 6, 2026, with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $6,170.48 firm fixed price contract is for the supply of NUCYNTA ER TABS 100MG pharmaceuticals, with a period of performance through February 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nucynta ER 200 mg tablets (60-count) valued at $2,965.27, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the company's larger...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $1,732 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical (DLA) to provide 60 tablets of 250mg Nucynta ER for pain management. Performance will take place in Conshohocken, Pennsylvania over one day in early September 2023. No additional details were provided on the original solicitation or whether this delivery order was placed against an existing DLA-managed...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Nucynta ER 50 mg tablets in quantities of 60 units. The contract carries a ceiling value of $1,414.00 and features firm fixed pricing with an ultimate completion date of July 25, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's existing...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCJ50Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,588.37 to AmerisourceBergen Drug Corp for the supply of Nucynta ER Tabs 200mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by January 13, 2026. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the primary contract vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the parent IDC with DLA Troop Support Medical. This delivery order exemplifies the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, demonstrating its capability to efficiently fulfill government contracts for essential medications required by military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 1/11/26 |